Activation of KRAS promotes the mesenchymal features of basal-type breast cancer

被引：69
作者：
Kim, Rae-Kwon [1 ]
Suh, Yongjoon [1 ]
Yoo, Ki-Chun [1 ]
Cui, Yan-Hong [1 ]
Kim, Hyeonmi [1 ]
Kim, Min-Jung [2 ]
Kim, In Gyu [3 ]
Lee, Su-Jae [1 ]
机构：
[1] Hanyang Univ, Dept Life Sci, Res Inst Nat Sci, Seoul 133791, South Korea
[2] Korea Inst Radiol & Med Sci, Natl Radiat Emergency Med Ctr, Lab Radiat Exposure & Therapeut, Seoul, South Korea
[3] Korea Atom Energy Res Inst, Dept Radiat Biol, Environm Radiat Res Grp, Taejon, South Korea
来源：
EXPERIMENTAL AND MOLECULAR MEDICINE | 2015年 / 47卷
基金：
新加坡国家研究基金会;
关键词：
GENE-EXPRESSION; RAS ONCOGENES; SLUG; TRANSITIONS; PROGRESSION; MUTATIONS; PHENOTYPE; SURVIVAL; VARIANT;
D O I：
10.1038/emm.2014.99
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Basal-type breast cancers are among the most aggressive and deadly breast cancer subtypes, displaying a high metastatic ability associated with mesenchymal features. However, the molecular mechanisms underlying the maintenance of mesenchymal phenotypes of basal-type breast cancer cells remain obscure. Here, we report that KRAS is a critical regulator for the maintenance of mesenchymal features in basal-type breast cancer cells. KRAS is preferentially activated in basal-type breast cancer cells as compared with luminal type. By loss and gain of KRAS, we found that KRAS is necessary and sufficient for the maintenance of mesenchymal phenotypes and metastatic ability through SLUG expression. Taken together, this study demonstrates that KRAS is a critical regulator for the metastatic behavior associated with mesenchymal features of breast cancer cells, implicating a novel therapeutic target for basal-type breast cancer.
引用
收藏
页码：e137 / e137
页数：9
相关论文
共 24 条
  • [1] Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
    Badve, Sunil
    Dabbs, David J.
    Schnitt, Stuart J.
    Baehner, Frederick L.
    Decker, Thomas
    Eusebi, Vincenzo
    Fox, Stephen B.
    Ichihara, Shu
    Jacquemier, Jocelyne
    Lakhani, Sunil R.
    Palacios, Jose
    Rakha, Emad A.
    Richardson, Andrea L.
    Schmitt, Fernando C.
    Tan, Puay-Hoon
    Tse, Gary M.
    Weigelt, Britta
    Ellis, Ian O.
    Reis-Filho, Jorge S.
    [J]. MODERN PATHOLOGY, 2011, 24 (02) : 157 - 167
  • [2] High Motility of Triple-negative Breast Cancer Cells Is Due to Repression of Plakoglobin Gene by Metastasis Modulator Protein SLUG
    Bailey, Charvann K.
    Mittal, Mukul K.
    Misra, Smita
    Chaudhuri, Gautam
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (23) : 19472 - 19486
  • [3] Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer
    Choi, Yoomi
    Lee, Hee Jin
    Jang, Min Hye
    Gwak, Jae Moon
    Lee, Kyu Sang
    Kim, Eun Joo
    Kim, Hyun Jeong
    Lee, Hee Eun
    Park, So Yeon
    [J]. HUMAN PATHOLOGY, 2013, 44 (11) : 2581 - 2589
  • [4] Ras proteins in the control of the cell cycle and cell differentiation
    Crespo, P
    León, J
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (11) : 1613 - 1636
  • [5] Involvement of ras activation in human breast cancer cell signaling, invasion, and anoikis
    Eckert, LB
    Repasky, GA
    Ülkü, AS
    McFall, A
    Zhou, H
    Sartor, CI
    Der, CJ
    [J]. CANCER RESEARCH, 2004, 64 (13) : 4585 - 4592
  • [6] An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
    Gyoerffy, Balazs
    Lanczky, Andras
    Eklund, Aron C.
    Denkert, Carsten
    Budczies, Jan
    Li, Qiyuan
    Szallasi, Zoltan
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2010, 123 (03) : 725 - 731
  • [7] Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines
    Hollestelle, Antoinette
    Elstrodt, Fons
    Nagel, Jord H. A.
    Kallemeijn, Wouter W.
    Schutte, Mieke
    [J]. MOLECULAR CANCER RESEARCH, 2007, 5 (02) : 195 - 201
  • [8] Triple-Negative Breast Cancer: An Unmet Medical Need
    Hudis, Clifford A.
    Gianni, Luca
    [J]. ONCOLOGIST, 2011, 16 : 1 - 11
  • [9] Ras oncogenes: split personalities
    Karnoub, Antoine E.
    Weinberg, Robert A.
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2008, 9 (07) : 517 - 531
  • [10] Metastatic Behavior of Breast Cancer Subtypes
    Kennecke, Hagen
    Yerushalmi, Rinat
    Woods, Ryan
    Cheang, Maggie Chon U.
    Voduc, David
    Speers, Caroline H.
    Nielsen, Torsten O.
    Gelmon, Karen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) : 3271 - 3277
123